Physician profile
Jay E Dujon
NPI 1578734158
$11,255.52
in general payments reported to CMS, 2019-2025
12 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,818 · 2020: $191 · 2021: $26.50 · 2022: $1,430 · 2023: $603 · 2024: $22.88 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $512 · Travel and Lodging: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $512.18 |
| Travel and Lodging | $276.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,712.11 | 2019 | |
| W. L. Gore & Associates, INC. | $1,572.18 | 2020-2025 | Gore Synecor Biomaterial, Gore Synecor Preperitoneal Biomaterial |
| Cook Biotech Incorporated | $450.63 | 2023 | Biodesign, Oasis |
| Medtronic, INC. | $152.57 | 2023 | Stealthstation S8 Platform |
| Tela Bio, INC. | $146.89 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $106.25 | 2019 | |
| Braintree Laboratories, INC. | $26.50 | 2021 | |
| Integra Lifesciences Corporation | $23.91 | 2022 | |
| Depuy Synthes Sales INC. | $23.63 | 2022 | |
| Convatec INC. | $14.77 | 2020 | |
| Conmed Corporation | $13.09 | 2020 | |
| Boston Scientific Corporation | $12.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Dujon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.